The incidence of thyroid cancer is increasing rapidly in the United States and the past few years have seen dramatic shifts in the management of papillary and follicular thyroid cancer. Knowledge of these emerging trends is important to optimize patient care and endocrine referral patterns for head and neck surgeons performing thyroid surgery.
Explore this issue:December 2006
We really need to look at where we stand in what I think is going to turn out to be a clinical epidemic, said Shereen Ezzat, MD, Professor of Endocrinology and Metabolism at the University of Toronto and a senior scientist in the Division of Applied Molecular Oncology at the Ontario Cancer Institute.
Dr. Ezzat was one of a distinguished roster of endocrine, imaging, and surgical experts on hand to update attendees on the most current trends and evolving paradigms in the diagnosis and management of thyroid cancer at the recent American Academy of Otolaryngology-Head and Neck Surgery annual meeting in Toronto.